Table 1.
Originator Biologic Products and Their Corresponding Biosimilars
| Originator Biologic Product | Biosimilar |
|---|---|
| Infliximab (Remicade, Janssen) | CT-P13 (Inflectra or Remsima, Celltrion Healthcare) |
| Adalimumab (Humira, AbbVie) | ABP 501 (Amgen) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.